跳至主要内容
临床试验/NL-OMON55835
NL-OMON55835已完成不适用

Dose individualization of Antibiotics in ICU patients: to TDM or not to TDM and the effects on outcome (DOLPHIN-trial) - DOLPHI

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 486 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
486

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • All patients admitted to the adult general ICU wards and given standard of care
  • intravenous therapy of the target antibiotic are screened for participating in
  • Patients will be admitted to the cohorts based upon the following three cohorts:
  • 1. Main cohort (COVID-19 Negative, No continuous infusion)
  • 2. COVID-19 cohort (including continuous infusion)
  • 3. Continuous infusion cohort (COVID-19 Negative)
  • Antibiotic initiation based on clinical suspicion of infection and/or cultured
  • pathogens susceptible to the target drugs, initial dosage prescription, and
  • duration of therapy are at the discretion of the attending physician. , In
  • order to be eligible to participate in this study, a subject must also meet all
  • of the following criteria:
  • * *18 years of age
  • * Receiving intravenous antibiotic therapy of the target drugs (including
  • continuous infusion)
  • * Treatment should be aimed for at least 2 days.
  • * Written informed consent has been obtained from the patient or their legally
  • authorized representative.

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • * Pregnancy
  • * Patient already enrolled in this trial
  • * Antibiotic cessation before sampling
  • * Medium care and burn wound patients admitted to the ICU
  • * Patients receiving target antibiotics only as prophylaxis within the context
  • of Selective Digestive tract Decontamination (SDD)

研究者

相似试验

Dose individualization of Antibiotics in ICU... | 临床试验